Clinical Trials Browser

Phase 3 × Lymphoma, B-Cell × Bortezomib × Clear all

NCT00312845 2012-06-25

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase 3 Completed

676 enrolled 10 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell